See also stories tagged with Nanoparticle
An AI assistant helped University of Colorado Boulder researchers solve a mathematical problem that had challenged their lab for a year and a half, though it made subtle errors along the way. The breakthrough could improve ...
The COVID vaccine is perhaps the first thing many people think of when they hear about mRNA-based drugs. Small packages of genetic material are sent into the body, prompting cells to produce useful proteins in the fight against ...
What does a clean room smell like? Many people say citrus, pine, or flowers because these fragrances are common in cleaning products. A research team led by Brandon Boor found that scent compounds in cleaning products—conventional ...
The adult human brain has limited capacity to repair or regenerate neurons lost to Alzheimer's disease, the most common type of dementia. Existing treatments can slow disease progression but do not reverse cognitive decline. ...
The most common scientific approach for thinking about how condensation, freezing and other phase transitions begin is based in classical nucleation theory, which was developed about a century ago. Thousands of experiments ...
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Tianjin Medical University General Hospital have developed a bioinspired lipid nanoparticle (LNP) that can deliver ...
Fibrinogen, the abundant plasma protein best known for forming blood clots, may play a second and far less benign role during SARS-CoV-2 infection: acting as a molecular bridge that simultaneously hides the virus from neutralizing ...
A new nanoparticle vaccine could one day give patients immunity to the flu with fewer trips to the doctor and without requiring health officials to correctly guess which flu strains will become dominant each year.
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant subtypes of breast cancer, accounting for 15% to 20% of all cases. Unlike other breast cancers, TNBC lacks targetable receptors, leaving ...
In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to help deliver next-generation mRNA therapeutics, including vaccines to fight infectious diseases, ...
